The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
Open accessAbstract
Histone deacetylases (HDACs) act on histones within the nucleosome-bound promoter of human immunodeficiency virus type 1 (HIV-1) to maintain proviral latency. HDAC inhibition leads to promoter expression and the escape of HIV from latency. We evaluated the ability of the potent inhibitor recently licensed for use in oncology, suberoylanilide hydroxamic acid (SAHA; Vorinostat), selective for Class I HDACs, to induce HIV promoter expression in cell lines and virus production from the resting CD4(+) T cells of antiretroviral-treated, aviremic HIV-infected patients. In J89, a Jurkat T cell line infected with a single HIV genome encoding the enhanced green fluorescence protein (EGFP) within the HIV genome, SAHA induced changes at nucleosome 1 of the HIV promoter in chromatin immunoprecipitation (ChIP) assays in concert with EGFP expression. In the resting CD4(+) T cells of antiretroviral-treated, aviremic HIV-infected patients clinically achievable exposures to SAHA induced virus outgrowth ex vivo. These results suggest that potent, selective HDAC inhibitors may allow improved targeting of persistent proviral HIV infection, and define parameters for in vivo studies using SAHA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997) · Science · doi:10.1126/science.278.5341.1291 · Cited by 2,186
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Chun, T.-W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,977
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
Mann, B. S., Johnson, J. R., Cohen, M. H., Justice, R., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-10-1247 · Cited by 1,365
Marks, P. A., & Breslow, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1272 · Cited by 1,196
Histone acetylation and an epigenetic code
Turner, B. M. (2000) · BioEssays · doi:10.1002/1521-1878(200009)22:9<836::aid-bies9>3.0.co;2-x · Cited by 1,182
Discovery and development of SAHA as an anticancer agent
Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210204 · Cited by 626
Butler, L. M., Agus, D. B., Scher, H. I., Higgins, B., Rose, A., Cordon‐Cardo, C., Thaler, H. T., Rifkind, R. A., Marks, P. A., & Richon, V. M. (2000) · PubMed · Cited by 615
Van Lint, C., Emiliani, S., Ott, M., & Verdin, E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00449.x · Cited by 580
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
Lehrman, G., Hogue, I. B., Palmer, S., Jennings, C., Spina, C. A., Wiegand, A., Landay, A. L., Coombs, R. W., Richman, D. D., Mellors, J. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67098-5 · Cited by 510
Self-citationJordan, A., Defechereux, P., & Verdin, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1726 · Cited by 467
NF‐κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation
Williams, S. A., Chen, L., Kwon, H., Ruiz‐Jarabo, C. M., Verdin, E., & Greene, W. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600900 · Cited by 430
Histone acetylation reduces nucleosome core particle linking number change
Norton, V. G., Imai, B. S., Yau, P., & Bradbury, E. M. (1989) · Cell · doi:10.1016/0092-8674(89)90920-3 · Cited by 396
Recruitment of chromatin‐modifying enzymes by CTIP2 promotes HIV‐1 transcriptional silencing
Marban, C., Suzanne, S., Dequiedt, F., de Walque, S., Redel, L., Van Lint, C., Aunis, D., & Rohr, O. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601516 · Cited by 354
Coull, J. J., Romerio, F., Sun, J.-M., Volker, J. L., Galvin, K. M., Davie, J. R., Shi, Y., Hansen, U., & Margolis, D. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.6790-6799.2000 · Cited by 346
Self-citationHistone deacetylation in epigenetics: An attractive target for anticancer therapy
Mai, A., Massa, S., Rotili, D., Cerbara, I., Valente, S., Pezzi, R., Simeoni, S., & Ragno, R. (2005) · Medicinal Research Reviews · doi:10.1002/med.20024 · Cited by 319
Histone Acetylation and Chromatin Remodeling
Gregory, P. D., Wagner, K., & Hörz, W. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5187 · Cited by 274
Ylisastigui, L., Archin, N. M., Lehrman, G., Bosch, R. J., & Margolis, D. M. (2004) · AIDS · doi:10.1097/00002030-200405210-00003 · Cited by 254
Self-citationHe, G., & Margolis, D. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.2965-2973.2002 · Cited by 240
Self-citationCBF‐1 promotes transcriptional silencing during the establishment of HIV‐1 latency
Tyagi, M., & Karn, J. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601928 · Cited by 220
Jiang, G., Espeseth, A., Hazuda, D. J., & Margolis, D. M. (2007) · Journal of Virology · doi:10.1128/jvi.01208-07 · Cited by 218
Self-citationHistone acetylation as an epigenetic determinant of long-term transcriptional competence
Turner, B. M. (1998) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050122 · Cited by 204
Covalent modifications of histones: expression from chromatin templates
Davie, J. R. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80138-x · Cited by 199
Archin, N. M., Eron, J. J., Palmer, S., Hartmann-Duff, A., Martinson, J. A., Wiegand, A., Bandarenko, N., Schmitz, J. L., Bosch, R. J., Landay, A. L., et al. (2008) · AIDS · doi:10.1097/qad.0b013e3282fd6df4 · Cited by 186
Self-citationPazin, M. J., Sheridan, P. L., Cannon, K., Cao, Z., Keck, J. G., Kadonaga, J. T., & Jones, K. A. (1996) · Genes & Development · doi:10.1101/gad.10.1.37 · Cited by 186
Stability of the Latent Reservoir for HIV‐1 in Patients Receiving Valproic Acid
Siliciano, J. D., Lai, J., Callender, M., Pitt, E., Zhang, H., Margolick, J. B., Gallant, J. E., Cofrancesco, Jr., Moore, R. D., Gange, S. J., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/511823 · Cited by 182
Kutsch, O., Benveniste, E. N., Shaw, G. M., & Levy, D. N. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8776-8786.2002 · Cited by 168
Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir
Lerolle, N., Lamine, A., Chaix, M., Boufassa, F., Aboulker, J.-P., Costagliola, D. G., Goujard, C., Paller, C., Delfraissy, J., & Lambotte, O. (2008) · AIDS · doi:10.1097/qad.0b013e3282fd6ddc · Cited by 158
Kharroubi, A. E., Piras, G., Zensen, R., & Martin, M. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2535 · Cited by 134
Myers, L. E., McQuay, L. J., & Hollinger, F. B. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.3.732-739.1994 · Cited by 131
Quivy, V., Adam, E., Collette, Y., Demonté, D., Chariot, A., Vanhulle, C., Berkhout, B., Castellano, R., de Launoit, Y., Burny, A., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.11091-11103.2002 · Cited by 117
Interaction of Histone Acetylases and Deacetylases In Vivo
Yamagoe, S., Kanno, T., Kanno, Y., Sasaki, S., Siegel, R. M., Lenardo, M. J., Humphrey, G. W., Wang, Y., Nakatani, Y., Howard, B. H., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.1025-1033.2003 · Cited by 88
Polyamides Reveal a Role for Repression in Latency within Resting T Cells of HIV‐Infected Donors
Ylisastigui, L., Coull, J. J., Rucker, V. C., Melander, C., Bosch, R. J., Brodie, S. J., Corey, L., Sodora, D. L., Dervan, P. B., & Margolis, D. M. (2004) · The Journal of Infectious Diseases · doi:10.1086/423822 · Cited by 57
Self-citationKlichko, V. I., Archin, N. M., Kaur, R., Lehrman, G. K., & Margolis, D. M. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4570-4579.2006 · Cited by 42
Self-citation
Cited by
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure
Ho, Y.-C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I. S., Lai, J., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · Cell · doi:10.1016/j.cell.2013.09.020 · Cited by 1,405
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
Archin, N. M., Liberty, A. L., Kashuba, A. D., Choudhary, S. K., Kuruc, J. D., Crooks, A. M., Parker, D. C., Anderson, E. M., Kearney, M. F., Strain, M. C., et al. (2012) · Nature · doi:10.1038/nature11286 · Cited by 1,139
Self-citationShan, L., Deng, K., Shroff, N. S., Durand, C. M., Rabi, S. A., Yang, H.-C., Zhang, H., Margolick, J. B., Blankson, J. N., & Siliciano, R. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.014 · Cited by 714
Rasmussen, T. A., Tolstrup, M., Brinkmann, C. R., Olesen, R., Erikstrup, C., Solomon, A., Winckelmann, A., Palmer, S., Dinarello, C., Buzon, M., et al. (2014) · The Lancet HIV · doi:10.1016/s2352-3018(14)70014-1 · Cited by 628
Deeks, S. G. (2012) · Nature · doi:10.1038/487439a · Cited by 604
Metadata
- Authors
- Archin, N. M., Espeseth, A., Parker, D., Cheema, M., Hazuda, D., & Margolis, D. M.
- Venue
- AIDS Research and Human Retroviruses
- Publisher
- SAGE Publications
- Published
- 2009-02
- Volume
- 25
- Issue
- 2
- Pages
- 207-212
- ISSN
- 0889-2229 (ISSN-L)
- 1931-8405
- OpenAlex
- W2051879794
- Cited by
- 336
- References
- 36
- FWCI
- 9.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.